OBJECTIVE	To evaluate the relationship between activated partial thromboplastin time ( aPTT ) and clinical outcomes in the Global Use of Strategies to Open Occluded Coronary Arteries ( GUSTO-V ) trial comparing standard-dose reteplase to half-dose reteplase and abciximab .\